Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$918,030,501
New position
Shares Held
4,654,855
first reported quarter
Ownership
0.300%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 94.22156007007737.ToString("F0")%
Shared 0.ToString("F0")%
None 5.778439929922629.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FIL Ltd holds $2,178,098,286 across 11 Drug Manufacturers - General names. AZN ranks #1 (42.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
4,654,855 | $918,030,501 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,278,815 | $380,810,128 | |
| 3 | PFE |
Pfizer Inc
|
8,751,327 | $245,737,262 | |
| 4 | LLY |
ELI LILLY & Co
|
191,147 | $175,811,276 | |
| 5 | ABBV |
AbbVie Inc.
|
570,535 | $124,085,657 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
875,527 | $122,022,197 | |
| 7 | MRK |
Merck & Co., Inc.
|
597,352 | $71,855,472 | |
| 8 | JNJ |
Johnson & Johnson
|
249,664 | $61,027,868 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $918,030,501 | 4,654,855 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||